Emerging Guidance for Managing Hepatorenal Syndrome

Welcome!

Thank you for participating in the CLDF symposium, Emerging Guidance for Managing Hepatorenal Syndrome. 

Please select “Register/Take Course” to complete the following:

  • Program Evaluation

Upon completion, you will receive your accreditation certificate. 

TIPS ON ACCESSING THE PLATFORM & COMPLETING YOUR PROFILE

  • If you already have a profile, please sign in and select Take Course.

 

  • First-time users will be asked to “register” for the platform by creating a profile/account.
    • When accessing the platform, select Register to set up your online profile.
    • You will need to create a username (your email) and password to set up a short profile within the platform before gaining access.
    • While completing your profile, please enter your license number in the Board Certification & Licensure section (if applicable):
      • Nursing license number
      • National Association of Boards of Pharmacy (NABP) number
      • American Board of Internal Medicine’s (ABIM) number

 

 

Target Audience

This activity has been designed to meet the educational needs of hepatologists and other healthcare professionals involved in the management of patients with common complications of cirrhosis and hepatorenal syndrome (HRS).

Learning Objectives

  • Identify, screen, and diagnose HRS
  • Discuss the HRS management guidelines and apply these criteria in clinical practice
  • Identify new advancements in the treatment of HRS

 

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 AMA PRA Category 1 Credit™ (Non- MD)
Course opens: 
10/28/2022
Course expires: 
11/06/2023
Rating: 
0

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the New Mexico Medical Society (NMMS) through the joint providership of Rehoboth McKinley Christian Health Care Services (RMCHCS) and The Chronic Liver Disease Foundation. RMCHCS is accredited by the NMMS to provide continuing medical education for physicians.

RMCHCS designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Disclosure of Conflicts of Interest

All faculty, staff, and reviewers involved in the planning, review, or presentation of continuing education activities sponsored/provided by Rehoboth McKinley Christian Health Care Services (RMCHCS) are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation and/or enduring material. 

Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Note that all relevant financial relationships, if any, have been mitigated. All additional planning committee members, staff, and reviewers of Rehoboth McKinley Christian Health Care Services (RMCHCS) and the Chronic Liver Disease Foundation have no relationships to disclose.

 

Americans with Disabilities Act: The event staff will be glad to assist you with any special needs (i.e., physical, dietary). 

 

Supported by an educational grant from Mallinckrodt Pharmaceuticals.

Presented for attendees of The Liver Meeting® 2022. This event/function is provided by the Chronic Liver Disease Foundation and supported by Mallinckrodt. This is not an official event/function of the American Association for the Study of Liver Diseases.

 

Accredited by:

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 AMA PRA Category 1 Credit™ (Non- MD)
Please login or register to take this course.